Parkinson's disease: Lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons

Acta Neuropathologica

Volumn 113, Issue 4, 2007, Pages 421-429

  Braak, Heiko ^a   Sastre, Magdalena ^a   Bohl, Jürgen R E ^b   Vos, Rob A I ^c   Del Tredici, Kelly ^a  

^a GOETHE UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c Laboratorium Pathologie Oost Nederland   (Netherlands)

Author keywords

Lamina I; Lewy neurites bodies; Pain; Parkinson's disease; Spinal cord

Indexed keywords

ALPHA SYNUCLEIN; MACROGOL;

ADRENERGIC TRANSMISSION; ADULT; AGED; ARTICLE; AUTOPSY; CELIAC GANGLION; CELL INCLUSION; CLINICAL ARTICLE; EMBEDDING; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; PAIN; PARASYMPATHETIC NERVE CELL; PARKINSON DISEASE; PATHOGENESIS; POSTGANGLIONIC NERVE; PREGANGLIONIC NERVE CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; SPINAL CORD DISEASE; SPINAL CORD DORSAL HORN; SYMPATHETIC NERVE CELL; THORACIC SPINAL CORD; TRIGEMINAL NUCLEUS; VAGUS NERVE;

AGED; AGED, 80 AND OVER; ALPHA-SYNUCLEIN; FEMALE; GANGLIA, PARASYMPATHETIC; GANGLIA, SYMPATHETIC; HUMANS; MALE; MIDDLE AGED; NEURONS; PARKINSON DISEASE; PERIPHERAL NERVOUS SYSTEM; POSTERIOR HORN CELLS;

EID: 33947200337     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-007-0193-x     Document Type: Article

References (112)

1. Abbott RD, Petrovitch H, White LR, Masaki KH, Tanner CM, Curb JD, Grandinetti A, Blanchette PL, Popper JS, Ross GW (2001) Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 57:456-462
2. Adler CH (2005) Nonmotor complications in Parkinson's disease. Mov Disord 20(Suppl 11):23-29
3. Ahlskog JE (2005) Challenging conventional wisdom: The etiologic role of dopamineoxidative stress in Parkinson's disease. Mov Disord 20:271-282
4. Awerbuch GI, Sandyk R (1994) Autonomic functions in the early stages of Parkinson's disease. Int J Neurosci 74:9-16
5. Benarroch EE (2001) Pain-autonomic interactions: A selective review. Clin Auton Res 11:343-349
6. Benarroch EE, Schmeichel AM, Low PA, Boeve BF, Sandroni P, Parisi J (2005) Involvement of medullary regions controlling sympathetic output in Lewy body disease. Brain 128:338-344
7. Blessing WW (2004) Lower brain stem regulation of visceral, cardiovascular, and respiratory function. In: Paxinos G, Mai JK (eds) The human nervous system, 2nd edn. Elsevier, San Diego, pp 464-478
8. Bloch A, Probst A, Bissig H, Adams H, Tolnay M (2006) α-Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects. Neuropathol Appl Neurobiol 12:284-295
9. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259
10. Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1:213-216
11. Braak H, Del Tredici K (2004) Poor and protracted myelination as a contributory factor to neurodegenerative disorders. Neurobiol Aging 25:19-23
12. Braak H, Del Tredici K (2005) Preclinical and clinical stages of intracerebral inclusion body pathology in idiopathic Parkinson's disease. In: Willow JM (ed) PaPkinson's disease: progress in research, Nova Science, Hauppauge, pp 1-49
13. Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197-211
14. Braak H, Rüb U, Gai WP, Del Tredici K (2003) Idiopathic Parkinson's disease: Possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen. J Neural Transm 110:517-536
15. Braak H, Rüb U, Del Tredici K (2003) Involvement of precerebellar nuclei in multiple system atrophy. Neurobiol Appl Neurobiol 29:60-76
16. Braak H, Ghebremedhin E, Rüb U, Bratzke H, Del Tredici K (2004) Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res 318:121-134
17. Braak H, de Vos RAI, Bohl J, Del Tredici K (2006) Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 396:67-72
18. Braak H, Alafuzoff I, Arzberger T, Kretzschmar H, Del Tredici K (2006) Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol 112:389-404
19. Buzas B, Max MB (2004) Pain in Parkinson disease. Neurology 62:2156-2157
20. Chaudhuri KR, Healy DG, Schapira AH (2006) Non-motor symptoms of Parkinson's disease: Diagnosis and management. Lancet Neurol 5:235-245
21. Craig AD (1992) Spinal and trigeminal lamina I input to the locus coeruleus anterogradely labeled with Phaseolus vulgaris leucoagglutinin (PHA-L) in the cat and the monkey. Brain Res 584:325-328
22. Craig AD (1993) Propriospinal input to thoracolumbar sympathetic nuclei from cervical and lumbar lamina I neurons in the cat and monkey. J Comp Neurol 331:517-530
23. Craig AD (1996) An ascending general homeostatic afferent pathway originating in lamina I. Prog Brain Res 107:225-242
24. Craig AD (2003) Pain mechanisms: Labeled lines versus convergence in central processing. Ann Rev Neurosci 26:1-30
25. de Lau LM, Koudstaal PJ, Hofman A, Breteler MM (2006) Subjective complaints precede Parkinson's disease: The Rotterdam study. Arch Neurol 63:362-365
26. Del Tredici K, Braak H (2004) Idiopathic Parkinson's disease: Staging an α-synucleinopathy with a predictable pathoanatomy. In: Kahle P, Haass C (eds) Molecular mechanisms in Parkinson's disease. Landes Bioscience, Georgetown, pp 1-32
27. Del Tredici K, Rüb U, de Vos RAI, Bohl JRE, Braak H (2002) Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413-426
28. Djaldetti R, Shifrin A, Rogowski Z, Sprecher E, Melamed E, Yarnitsky D (2004) Quantitative measurement of pain sensation in patients with Parkinson disease. Neurology 62:2171-2175
29. Doty RL, Deems DA, Stellar S (1988) Olfactory dysfunction in parkinsonism: A general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 38:1237-1244
30. Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI (1992) Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 55:138-142
31. Duda JE, Lee VMY, Trojanowski JQ (2000) Neuropathology of synuclein aggregates: New insights into mechanism of neurodegenerative diseases. J Neurosi Res 61:121-127
32. Foley P, Riederer P (1999) Pathogenesis and preclinical course of Parkinson's disease. J Neural Transm Suppl 56:31-74
33. Ford B (1998) Pain in Parkinson's disease. Clin Neurosci 5:63-72
34. Foreman RD, Blair RW (1988) Central organization of sympathetic cardiovascular response to pain. Ann Rev Physiol 50:607-622
35. Forno LS (1969) Concentric hyaline intraneuronal inclusions of Lewy body type in the brain of elderly persons (50 incidental cases): Relationship to parkinsonism. J Am Geriatr Soc 17:557-575
36. Forno LS (1996) Neuropathology of Parkinson's disease. J Neuropathol Exp Neurol 55:259-272
37. Fürst S (1999) Transmitters involved in antinociception in the spinal cord. Brain Res Bull 48:129-141
38. Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson's disease. Arch Neurol 56:33-39
39. Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 51:745-752
40. Gibb WRG, Lees AJ (1989) The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol Appl Neurobiol 15:27-44
41. Goetz CG, Tanner CM, Levy M, Wilson RS, Garron DC (1986) Pain in Parkinson's disease. Mov Disord 1:45-49
42. Goetze O, Wieczorek J, Mueller T, Przuntek H, Schmidt WE, Woitalla D (2005) Impaired gastric emptying of a solid test meal in patients with Parkinson's disease using 13C-sodium octanoate breadth test. Neurosci Lett 375:170-173
43. Golbe LI (1999) Alpha synuclein and Parkinson's disease. Mov Disord 14:6-9
44. Goldstein DS (2006) Orthostatic hypotension as an early finding in Parkinson's disease. Clin Auton Res 16:46-54
45. Gonera EG, van't Hof M, Bergen HJ, van Weel C, Horstink MW (1997) Symptoms and duration of the prodromal phase in Parkinson's disease. Mov Disord 12:871-876
46. Guyenet PG, Koshiya N, Huangfu D, Baraban SC, Stornetta RL, Li YW (1996) Role of medulla oblongata in generation of sympathetic and vagal outflows. Prog Brain Res 107:127-144
47. Halliday G (2004) Substantia nigra and locus coeruleus. In: Paxinos G, Mai JK (eds) The human nervous system, 2nd edn, Elsevier, San Diego, pp 449-463
48. Hawkes CH, Shephard BC, Daniel SE (1997) Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry 62:436-446
49. Hawkes CH, Shephard BC, Daniel SE (1999) Is Parkinson's disease a primary olfactory disorder? Q J Med 92:473-480
50. Hilz MJ, Axelrod FB, Braeske K, Stemper B (2002) Cold pressor test demonstrates residual sympathetic cardiovascular activation in familial dysautonomia. J Neurol Sci 196:81-89
51. Hopkins DA, Bieger D, de Vente J, Steinbusch HWM (1996) Vagal efferent projections: Viscerotopy, neurochemistry and effects of vagotomy. Progr Brain Res 107:79-96
52. Huang XF, Törk I, Paxinos G (1993) Dorsal motor nucleus of the vagus nerve: A cyto- and chemoarchitectonic study in the human. J Comp Neurol 330:158-182
53. Huang XF, Paxinos G (1995) Human intermediate reticular zone: A cyto- and chemoarchitectonic study. J Comp Neurol 360:571-588
54. Iwanaga K, Wakabayashi K, Yoshimoto M, Tomita I, Satoh H, Takashima H, Satoh A, Seto M, Tsujihata M, Takahashi H (1999) Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases. Neurology 52:1269-1271
55. Jänig W (1996) Spinal cord reflex organization of sympathetic systems. Progr Brain Res 107:43-77
56. Jager W, den Hartog WA, Bethlem J (1960) The distribution of Lewy bodies in the central and autonomic nervous system in idiopathic paralysis agitans. J Neurol Neurosurg Psychiat 23:283-290
57. Jellinger K (1991) Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 14:153-197
58. Jellinger KA (2003) Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: Incidence and topographic distribution - a pilot study. Acta Neuropathol 106:191-201
59. Jellinger KA (2004) Lewy body-related α-syncleinopathy in the aged human brain. J Neural Transm 111:1219-1235
60. Jenner P (1993) Presymptomatic detection of Parkinson's disease. J Neural Transm Suppl 40:23-36
61. Jensen PH, Gai WP (2001) Alpha-synuclein. Axonal transport, ligand interaction, and neurodegeneration. In: Tolnay M, Probst A (eds) Neuropathology and genetics of dementia. Kluwer/Plenum, New York, pp 129-134
62. Jost WH (2003) Autonomic dysfunctions in idiopathic Parkinson's disease. J Neurol 250(Suppl 1):28-30
63. Kaufmann H, Nahm K, Purohit D, Wolfe D (2004) Autonomic failure as the initial manifestation of Parkinson's disease and dementia with Lewy bodies. Neurology 63:1093-1095
64. Klos KJ, Ahlskog JE, Josephs KA, Apaydin H, Parisi JE, Boeve BF, DeLucia MW, Dickson DW (2006) α-Synuclein pathology in the spinal cord of neurologically asymptomatic aged individuals. Neurology 66:1100-1102
65. Klosen P, Maessen X, van den Bosch de Aguilar P (1993) PEG embedding for immunocytochemistry: Application to the analysis of immunoreactivity loss during histological processing. J Histochem Cytochem 41:455-463
66. Koller WC, Montgomery EB (1997) Issues in the early diagnosis of Parkinson's disease. Neurology 49(Suppl 1):10-25
67. Koller WC, Langston JW, Hubble JP, Irwin I, Zack M, Golbe L, Forno L, Ellenberg J, Kurland L, Ruttenber AJ (1991) Does a long preclinical period occur in Parkinson's disease? Neurology 41(Suppl 2):8-13
68. Korczyn AD (1990) Autonomic nervous system disturbances in Parkinson's disease. Adv Neurol 53:463-468
69. Kuusisto E, Parkkinen L, Alafuzoff I (2003) Morphogenesis of Lewy bodies: Dissimilar incorporation of α-synuclein, ubiquitin, and p62. J Neuropathol Exp Neurol 62:1241-1253
70. Lang AE, Obeso JA (2004) Challenges in Parkinson's disease: Restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol 3:309-316
71. Langston JW (2006) The Parkinson's complex: Parkinsonism is just the tip of the iceberg. Ann Neurol 59:591-596
72. Larner AJ, Mathias CJ, Rossor MN (2000) Autonomic failure preceding dementia with Lewy bodies. J Neurol 247:229-231
73. Lee PH, Yeo SH, Kim HJ, Youm HY (2006) Correlation between cardiac 123 I MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy. Mov Disord 21:1975-1977
74. Light AR (1988) Normal anatomy and physiology of the spinal cord dorsal horn. Appl Neurophysiol 51:78-88
75. Litvan I, Bhatia KP, Burn DJ, Goetz CG, Lang AE, McKeith I, Quinn N, Sethi KP, Shults C, Wenning GK (2003) SIC Task force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18:467-486
76. Loewy AD (1990) Central autonomic pathways. In: Loewy AD, Spyer KM (eds) Central regulation of autonomic functions. Oxford University Press, New York, pp 88-103
77. Lowe J (1994) Lewy bodies. In: Calne DP (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 51-69
78. Magerkurth C, Schnitzer R, Braune S (2005) Symptoms of autonomic failure in Parkinson's disease: Prevalence and impact on daily life. Clin Auton Res 15:76-82
79. Martignoni E, Pacchetti C, Godi L, Miceli G, Nappi G (1995) Autonomic disorders in Parkinson's disease. J Neural Transm 45(Suppl):11-19
80. McHugh JM, McHugh WB (2000) Pain: Neuroanatomy, chemical mediators, and clinical implications. AACN Clin Issues 2:168-178
81. Micieli G, Tosi P, Marcheselli S, Cavallini A (2003) Autonomic dysfunction in Parkinson's disease. Neurol Sci 24:32-34
82. Mikolaenko I, Pletnikova O, Kawas CH, O'Brien R, Resnick SM, Crain B, Troncosco JC (2005) Alpha-synuclein lesions in normal aging, Parkinson disease, and Alzheimer disease: Evidence from the Baltimore Longitudinal Study of Aging (BLSA). J Neuropathol Exp Neurol 64:156-162
83. Neumann M, Müller V, Kretzschmar HA, Haass C, Kahle PJ (2004) Regional distribution of proteinase-K-resistant α-synuclein correlates with Lewy body disease stage. Neuropathol Exp Neurol 63:1225-1235
84. Pfeiffer RF (2003) Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 2:107-116
85. Ponsen MM, Stoffers D, Booij J, van Eck-Smit BL, Wolters EC, Berendse HW (2004) Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 56:173-181
86. Przuntek H, Müller T, Riederer P (2004) Diagnostic staging of Parkinson's disease: Conceptual aspects. J Neural Transm 111:201-216
87. Quigley EM (1996) Gastrointestinal dysfunction in Parkinson's disease. Semin Neurol 16:245-250
88. Ross GW, Abbott RD, Petrovitch H, Tanner CM, Davis DG, Nelson J, Markesbery WR, Hardman J, Masaki K, Launer L, White LR (2006) Association of olfactory dysfunction with incidental Lewy bodies. Mov Disord 21(Suppl 13):2-6
89. Sage JI (2004) Pain in Parkinson's disease. Curr Treat Options Neurol 6:191-200
90. Scherder E, Wolters E, Polman C, Serfeant J, Swaab D (2005) Pain in Parkinson's disease and multiple sclerosis: Its relation to the medial and lateral pain systems. Neurosci Biobehav Rev 29:1047-1056
91. Siddiqui MF, Rast S, Lynn MJ, Auchus AP, Pfeiffer RF (2002) Autonomic dysfunction in Parkinson's disease: A comprehensive symptom survey. Parkinsonism Rel Disord 8:277-284
92. Smithson KG, MacVicar BA, Hatton GI (1983) Polyethylene glycol embedding: A technique compatible with immunocytochemistry, enzyme histochemistry, histofluorescence and intracellular staining. J Neurosci Methods 7:27-41
93. Soykan I, Lin Z, Bennet JP, McCallum RW (1999) Gastric myoelectrical activity in patients with Parkinson's disease: Evidence of a primary gastric abnormality. Digest Disease Sci 44:927-931
94. Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Goedert M (1997) α-Synuclein in Lewy bodies. Nature 388:2045-2047
95. Strack AM, Sawyer WB, Hughes JH, Platt KB, Loewy AD (1989) A general pattern of CNS innervation of the sympathetic outflow demonstrated by transneuronal pseudorabies viral infections. Brain Res 491:156-162
96. Strack AM, Sawyer WB, Platt KB, Loewy AD (1989) CNS cell groups regulating the sympathetic outflow to adrenal gland as revealed by transneuronal cell body labelling with pseudorabies virus. Brain Res 491:274-296
97. Sun MK (1995) Central neural organization and control of sympathetic nervous system in mammals. Prog Neurobiol 47:157-233
98. Takahashi H, Wakabayashi K (2001) The cellular pathology of Parkinson's disease, Neuropathol 21:315-322
99. Takahashi H, Wakabayashi K (2005) Controversy: Is Parkinson's disease a single disease entity? Yes. Parkinsonism Rel Disord 11:31-37
100. Thal DR, Del Tredici K, Braak H (2004) Neurodegeneration in normal brain aging and disease. Sci Aging Knowl Environ 23:1-13
101. Tracey I (2005) Nociceptive processing in the human brain. Curr Opin Neurobiol 15:478-487
102. Uchikado H, Lin WL, DeLucia MW, Dickson DW (2006) Alzheimer disease with amgydala Lewy bodies: A distinct form of alpha-synucleinopathy. J Neuropathol Exp Neurol 65:685-697
103. Wakabayashi K, Takahashi H (1997) The intermediolateral nucleus and Clarke's column in Parkinson's disease. Acta Neuropathol 94:287-289
104. Wakabayashi K, Takahashi H (1997) Neuropathology of autonomic nervous system in Parkinson's disease. Eur Neurol 38(Suppl 2):2-7
105. Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F (1988) Parkinson's disease: The presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol 76:217-221
106. Wakabayashi K, Takahashi H, Ohama E, Ikuta F (1990) Parkinson's disease: an immunohistochemical study of Lewy body-containing neurons in the enteric nervous system, Acta Neuropathol 79:581-583
107. Wakabayashi K, Takahashi H, Ohama E, Takeda S, Ikuta F (1993) Lewy bodies in the visceral autonomic nervous system in Parkinson's disease. Adv Neurol 60:609-612
108. Waseem S, Gwinn-Hardy K (2001) Pain in Parkinson's disease. Postgrad Med 110:1-5
109. Willis WD (1985) The pain system: The neural basis of nociceptive transmission in the mammalian nervous system. In: Gildenberg PL (ed) Pain and headache. Karger, Basel
110. Willis WD, Westlund KN (1997) Neuroanatomy of the pain system and of the pathways that modulate pain. J Clin Neurophysiol 14:2-31
111. Wolters EC, Braak H (2006) Parkinson's disease: Premotor clinico-pathological correlations. J Neural Transm 70(Suppl):309-319
112. Wolters EC, Francot C, Bergmans P, Winogrodzka A, Booij J, Berendse HW, Stoof JC (2000) Preclinical (premotor) Parkinson's disease. J Neurol 247(Suppl 2):103-109